• Asunaprevir: From Protease Assay to Translational Design

  2026-08-28

  Asunaprevir (BMS-650032) is examined here through a translational assay-design lens, connecting HCV NS3 protease pharmacology with lessons from a rigorous NUT carcinoma chemical screen. Learn how to distinguish enzymatic inhibition, HCV RNA replication inhibition, cellular toxicity, and exposure-related effects in reproducible antiviral workflows.

• Cyclo (-RGDfC) for Spatial Angiogenesis Assays

  2026-08-28

  Cyclo (-RGDfC) connects αvβ3 integrin biology with spatially controlled hydrogel assays. This article explains how c(RGDfC) can be incorporated into reproducible angiogenesis research workflows inspired by open-platform digital light printing.

• iRhom2 in Olfaction: Receptor Regulation and Adaptation

  2026-08-27

  Azzopardi and colleagues identify iRhom2 as an olfactory sensory neuron-enriched regulator connected to odorant receptor expression and activity-dependent adaptation. Combining knockout mice, transcriptomics, in situ hybridization, single-cell analysis, and a heterologous receptor model, the study supports an odor-responsive iRhom2/ADAM17 signaling circuit while defining important limits for causal interpretation.

• ARCA EGFP mRNA for Transfection Controls

  2026-08-27

  ARCA EGFP mRNA provides a fast, directly visible readout of mRNA delivery and protein expression in mammalian cells. Its ARCA cap and approximately 100-nucleotide poly(A) tail support robust translation, making it useful for optimizing lipid reagents, lipid nanoparticles, cell models, and fluorescence-based transfection assays.

• IPA-3 for Reliable Pak1 Cell Assays

  2026-08-26

  Learn how IPA-3 (SKU B2169) can improve the interpretation of Pak1-linked viability, proliferation, and cytotoxicity experiments. This scenario-based guide covers mechanism, solvent compatibility, dose selection, negative controls, and practical vendor evaluation.

• WDR36, Glycolysis, and Human Blastoid Formation

  2026-08-26

  This study identifies WDR36 as a regulator of human blastoid formation and trophectoderm commitment, linking the protein to glycolytic metabolism through an interaction with LDHA. Its combined use of mouse embryos, human stem-cell-derived blastoids, transcriptomics, and targeted metabolomics provides a mechanistic framework for studying metabolic control of early embryonic lineage decisions.

• Pazopanib Hydrochloride: Mechanism and Research Use

  2026-08-25

  Pazopanib Hydrochloride, also known as GW786034, is an oral multi-target receptor tyrosine kinase inhibitor with anti-angiogenic activity. Its kinase-panel data, clinical indications, and distinct in vitro response metrics support a structured framework for renal cell carcinoma treatment research and soft tissue sarcoma therapy studies.

• AR Heterogeneity and Castration Resistance in Prostate Cance

  2026-08-25

  The reference study shows that androgen receptor (AR) heterogeneity is functionally linked to distinct castration and enzalutamide responses in advanced prostate cancer. By combining patient specimens, xenografts, genome-edited LNCaP models, transcriptomics, and combination treatment experiments, the authors identify BCL-2 as a potential therapeutic vulnerability in AR-low or AR-negative disease.

• Phosbind Acrylamide Workflow for Phosphoproteins

  2026-08-24

  Phosbind Acrylamide enables antibody-free separation of phosphorylated and non-phosphorylated proteins in SDS-PAGE. This workflow shows how to apply it to kinase assays, signal-transduction studies, and mechanistic apoptosis models while preserving practical controls and troubleshooting discipline.

• Phosphatase Inhibitor Cocktail: Practical 100X Guide

  2026-08-24

  Phosphatase Inhibitor Cocktail (2 Tubes, 100X) helps limit post-collection dephosphorylation during lysate preparation for immunoblotting, immunoprecipitation, kinase assays, and mass spectrometry. Its dual-component formulation should be added sequentially and validated for assay compatibility; it is not a substitute for controlling harvest time, temperature, or downstream matrix effects.

• Ceftolozane Sulfate: From PBP3 to PK/PD

  2026-08-23

  A translational framework for connecting Ceftolozane sulfate mechanism, susceptibility testing, animal models, and exposure-guided strategy against resistant Pseudomonas aeruginosa.

• SARS-CoV-2 Release Factors Revealed by RNAi

  2026-08-22

  Kerr et al. developed an arrayed, druggable-genome RNA interference screen designed to capture host factors acting across the SARS-CoV-2 replication and reinfection cycle, including late assembly and release. The study identifies a conserved Rab11a-associated vesicular transport program and shows that pharmacological CDK9 inhibition with CDKI-73 can prevent viral release, providing a mechanistic starting point for host-directed antiviral research.

• EdU Flow Cytometry Assay Kits (Cy5) for CRC

  2026-08-22

  Discover how EdU Flow Cytometry Assay Kits (Cy5) convert S-phase DNA synthesis into a sensitive, multiplex-compatible readout for colorectal cancer models. This workflow complements metabolic and immune studies by separating tumor-cell proliferation from checkpoint-mediated immune evasion without harsh DNA denaturation.

• Ibrutinib (PCI-32765) BTK Inhibitor Guide

  2026-08-21

  A scenario-based guide to using Ibrutinib (PCI-32765) for reproducible BTK pathway and cell-viability studies. It explains assay design, solvent handling, interpretation, and selection of SKU A3001 for chronic lymphocytic leukemia research and related B-cell models.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-20

  Learn how to use the Fluorescein TSA Fluorescence System Kit to reveal weak protein and nucleic-acid signals in IHC, ICC, and ISH. A neuroscience case study shows how sensitive localization assays can support mechanistic work on transcranial K+-channelrhodopsin inhibition without confusing fluorescence intensity with functional efficacy.

7987 records 1/533 page Next 12345 下5页 Last page